Travis Alan Coy - 17 Feb 2026 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role: Chief Financial Officer
Signature: /s/ Lily Hepworth, Attorney-in-Fact
Issuer symbol: IMCR
Transactions as of: 17 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 17:00:28 UTC
Previous filing: 03 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Coy Travis Alan	Chief Financial Officer	C/O IMMUNOCORE HOLDINGS PLC, 92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM	/s/ Lily Hepworth, Attorney-in-Fact	19 Feb 2026	0001969524

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMCR	Restricted Share Units	Award	$0	+33,353		$0.000000	33,353	17 Feb 2026	Ordinary Shares	33,353		Direct	F1, F2, F3
transaction	IMCR	Employee Share Option (Right to Buy)	Award	$0	+95,637		$0.000000	95,637	17 Feb 2026	Ordinary Shares	95,637	$32.38	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted share unit ("RSU") represents a contingent right to receive one Ordinary Share.
F2	The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date.
F3	Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share.
F4	25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.